All Studies

Analysis of medicinal and therapeutic potential of Withania somnifera derivatives against COVID-19.

Researchers investigated thirty-nine natural compounds found in Ashwagandha, a medicinal plant. They found that Withanoside II is the most effective compound against COVID-19, and Withanoside III, IV, V, X, and XI also have favorable binding affinities. Molecular dynamics simulations confirmed the stable interactions between the compounds and the virus enzymes. The complexes formed between TMPRSS2-Withanolide Q and Mpro-Withanoside IV were the most stable. This research suggests that Ashwagandha compounds may have potential in treating COVID-19.

Gheshlaghi SZ et al (2023).
J Biomol Struct Dyn.
PubMed:
35993530

Integrating transcriptome and chemical analyses to reveal the anti-Alzheimer's disease components in Verbena officinalis Linn.

A study found that Linn., an herb in Chinese medicine, contains compounds that exhibit anti-Alzheimer's disease (AD) activity. The main chemical components were identified through ultra-performance liquid chromatography-mass spectrometry and subsequently used for molecular docking. The transcriptome analysis revealed that leaves had relatively high expression of the anti-AD compounds, and transcription factors may be involved in their biosynthesis. The study provides insights into the biosynthetic pathway of anti-AD components and the regulation mechanism of active components and furthers the potential of Linn. as a treatment for AD.

Peng S et al (2022).
Front Plant Sci.
PubMed:
35991454